araceli miranda retweeted
Now online in @NDTsocial
Peptide Epitope Mapping of Anti-nephrin antibodies in FSGS
🧐Patient plasma binding was restricted to a small subset of nephrin peptides
▶️ academic.oup.com/ndt/article…
8
14
656
15h
⎐كُـود⎐كوبِون⎐خـِصم⎐
⎐نون⎐
⊵S3Q⊴
⎐ايهرب⎐ايهيرب اهرب
⊵GCA5893⊴
⊴تيمو ⊴
⊵TEB72⊴
❮كارديال❯
A004
⎐نمشي⎐
⊵AABN⊴
⎐ريف⎐للعطور ⎐
⎐AX140⊴
ماكــس⎐
A9B
***
fSgs
📈 In the US, the prevalence of end-stage kidney disease (ESKD) attributed to focal segmental glomerulosclerosis (FSGS) increased from 7.65 per 100,000 in 2008 to 9.60 per 100,000 in 2018.
In FSGS, elevated proteinuria is associated with higher risk of kidney failure, cardiovascular events, and all-cause mortality in a retrospective observational analysis of real-world data (N=7,974).
👉Explore a summary of the findings here: dub.sh/GE5hpUi
Source: Bensink ME et al. Kidney Med. 2024;6(2):100760; Velez JCQ et al. Kidney360. 2024;5:1145-1153.
#FSGSAwareness #Nephrology #NephTwitter
MA-DS-26-0043 | June 2026
Jun 13
I don't think people realize how involved he is with FSGs other stuff lol
1
28
DrMad retweeted
Jun 12
Most common cause of nephrotic syndrome in children?
A. FSGS
B. Minimal change disease
C. Membranous nephropathy
D. Amyloidosis
9
2
13
1,797
Jun 12
Right but the board don’t operate like that. The board aren’t in the dressing room and the way Liverpool is run fans are always left clueless as to what’s going on. Someone needed to give the fans some insight that didn’t go through fsgs pr machine.
1
14
Jun 12
$TVTX
Here it comes my 50. Actually 52
I was right to call it derisked investment after FSGS approval
MC 4.8B is still below my price target of 7.5B. Hope to get there in 1 to 2 years ($82/share)
May 1
$TVTX ATH at $44.
Fairly derisked investment, MC only 4B
Waiting for $50 to declare another 10x investment in 2-3 years.
1
7
1,639
stockassassin retweeted
Jun 12
$TVTX 4.5B MC
CEO sees 3B in IgNA FSGS
Gugg projects 3.3B by 2032
After 2033 IgNA may face generics but should survive bc is listed in the FDA Orange book. FSGS to be listed soon
No competition in FSGS -> fast launch, same salesforce
My target 3B×2.5 =7.5B MC
Blue sky 9.9B
Jun 12
Wondering about the upside
1
1
9
2,873
Jun 12
今の所は原疾患が先天性腎疾患（低形成腎）それに伴う２次性/巣状分節性糸球体硬化症FSGSと!ネフローゼ症候群✖︎
「低血圧」🔄 腎保護で降圧剤継続（※高血圧既往❌）
腎臓の病名は違うけど皆さん上手く対処療法とどう向き合ってますか?高度蛋白尿には変わりないがステロイドは良い意味で適応外との事
Jun 12
3日位前〜💊自己断薬中!腎保護/降圧剤（高血圧既往❌）糖尿病既往❌ CKD適応SGLT2阻害薬は継続※医師も低血圧続くなら飲まなくても良いよ🙆♀️と降圧剤自体の効果? 当事者に浸透少なくメジャーでは無い頃〜（7.8年とか?）継続も低血圧で作用/量を調整!それでも蛋白尿↑ 尿に糖出す薬追加に!悪化したら怖い
9
555
